These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9864663)

  • 21. [Mediators involved in the nephrotoxicity of cyclosporin A].
    Simon N; Barré J; Jolliet P; Urien S; Tillement JP
    Therapie; 1997; 52(4):329-33. PubMed ID: 9437887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic cyclosporine nephrotoxicity.
    Andoh TF; Bennett WM
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):265-70. PubMed ID: 9617556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into chronic cyclosporine nephrotoxicity.
    Bennett WM
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):515-9. PubMed ID: 8937936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.
    Jain S; Bicknell GR; Nicholson ML
    Br J Surg; 2000 Nov; 87(11):1563-8. PubMed ID: 11091246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
    Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
    Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of tight junction proteins in cyclosporine nephrotoxicity.
    Lee CH; Kim S; Kang CM; Kim WY; Kim J; Kim GH
    Am J Nephrol; 2011; 33(1):7-16. PubMed ID: 21124021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.
    Linden GJ; Haworth SE; Maxwell AP; Poulton KV; Dyer PA; Middleton D; Irwin CR; Marley JJ; McNamee P; Short CD; Hull PS; James JA
    J Periodontol; 2001 Jun; 72(6):808-14. PubMed ID: 11453244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine nephrotoxicity.
    Busauschina A; Schnuelle P; van der Woude FJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):229S-233S. PubMed ID: 15041343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of ubiquinol, the reduced form of coenzyme Q10, on cyclosporine nephrotoxicity.
    Ishikawa A; Homma Y
    Int Braz J Urol; 2012; 38(2):230-4; discussion 234. PubMed ID: 22555041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides.
    Simonson MS; Dunn MJ
    J Lab Clin Med; 1992 Jun; 119(6):622-39. PubMed ID: 1317401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH
    Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
    Rodicio JL; Morales JM; Ruilope LM
    J Hypertens Suppl; 1993 Dec; 11(6):S21-5. PubMed ID: 8169378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin-related nephrotoxicity in children with nephrotic syndrome.
    Ganesan V; Milford DV; Taylor CM; Hulton SA; Parvaresh S; Ramani P
    Pediatr Nephrol; 2002 Mar; 17(3):225-6; author reply 227. PubMed ID: 11956868
    [No Abstract]   [Full Text] [Related]  

  • 37. Endothelin peptides and receptors in human kidney.
    Karet FE
    Clin Sci (Lond); 1996 Sep; 91(3):267-73. PubMed ID: 8869408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin.
    Ninova D; Covarrubias M; Rea DJ; Park WD; Grande JP; Stegall MD
    Transplantation; 2004 Aug; 78(3):338-44. PubMed ID: 15316360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling.
    O'Connell S; Tuite N; Slattery C; Ryan MP; McMorrow T
    Toxicol Sci; 2012 Mar; 126(1):101-13. PubMed ID: 22147139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
    J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.